Stock DNA
Pharmaceuticals & Biotechnology
RON 1,601 Million ()
19.00
NA
0.86%
-999,999.00
6.17%
1.73
Revenue and Profits:
Net Sales:
160 Million
(Quarterly Results - Mar 2025)
Net Profit:
33 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
387.0%
0%
387.0%
6 Months
387.0%
0%
387.0%
1 Year
387.0%
0%
387.0%
2 Years
387.0%
0%
387.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Antibiotice SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.64%
EBIT Growth (5y)
14.60%
EBIT to Interest (avg)
15.16
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
0
Tax Ratio
1.81%
Dividend Payout Ratio
13.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.67%
ROE (avg)
6.87%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
1.80
EV to EBIT
18.86
EV to EBITDA
12.73
EV to Capital Employed
1.64
EV to Sales
2.95
PEG Ratio
NA
Dividend Yield
0.81%
ROCE (Latest)
8.70%
ROE (Latest)
9.28%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
160.40
169.10
-5.14%
Operating Profit (PBDIT) excl Other Income
49.20
23.10
112.99%
Interest
1.00
1.10
-9.09%
Exceptional Items
0.00
0.00
Consolidate Net Profit
32.60
14.30
127.97%
Operating Profit Margin (Excl OI)
226.60%
65.80%
16.08%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is -5.14% vs 9.31% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is 127.97% vs 4.38% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
674.10
599.50
12.44%
Operating Profit (PBDIT) excl Other Income
150.50
125.30
20.11%
Interest
4.50
4.10
9.76%
Exceptional Items
0.00
-0.90
100.00%
Consolidate Net Profit
102.20
81.10
26.02%
Operating Profit Margin (Excl OI)
156.50%
162.40%
-0.59%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 12.44% vs 24.20% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 26.02% vs 57.48% in Dec 2023






